Koichi Matsuo
Overview
Explore the profile of Koichi Matsuo including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
212
Citations
3750
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakamura T, Kawaai K, Kuroda Y, Matsuo K
MethodsX
. 2025 Jan;
14():103136.
PMID: 39840024
Tartrate-resistant acid phosphatase (TRAP) staining is widely used to stain osteoclasts in histological bone sections. The red dye formed by the conventional TRAP enzymatic reaction using naphthol AS-MX (or AS-BI)...
2.
Matsuo K, Nehira T, Berova N, Pescitelli G, Trapp O, Collina S
Chirality
. 2025 Jan;
37(1):e70015.
PMID: 39807754
No abstract available.
3.
Nakano T, Irie K, Matsuo K, Mishima K, Nakamura Y
J Cereb Blood Flow Metab
. 2024 Nov;
:271678X241300223.
PMID: 39539186
In the central nervous system (CNS), neuronal function and dysfunction are critically dependent on mitochondrial integrity and activity. In damaged or diseased brains, mitochondrial dysfunction reduces adenosine triphosphate (ATP) levels...
4.
Kobayashi M, Takahashi J, Ota H, Matsuo K, Ibrahim M, Minato T, et al.
Chirality
. 2024 Nov;
36(11):e70004.
PMID: 39528420
The homochirality of life remains one of the most enigmatic issues in the study of the origin of life. A proposed mechanism for symmetry breaking involves irradiation by circularly polarized...
5.
Yamaguchi R, Uchiyama M, Miyazaki M, Hayashi T, Oyabu K, Nakano T, et al.
Cancer Diagn Progn
. 2024 Nov;
4(6):722-728.
PMID: 39502602
Background/aim: Trastuzumab (TRA) is a key drug in human epidermal growth factor receptor type 2 (HER2)-positive breast cancer treatment. Infusion reactions (IR) with TRA are frequently observed in practice. Although...
6.
Ibrahim M, Esmael M, Elmashi T, Haga T, Bayoumi R, Eldanasoury M, et al.
Chirality
. 2024 Oct;
36(10):e23722.
PMID: 39406398
The current study exploited cheese whey supernatant (CWS) as a renewable resource for polyhydroxyalkanoates (PHAs) formation. Structure identification and investigating the influence of lipid membranes' chemistry on PHA structuration were...
7.
Ibrahim M, Ibrahim H, Haga T, Ishida A, Nehira T, Matsuo K, et al.
J Fungi (Basel)
. 2024 Sep;
10(9).
PMID: 39330418
This research identified a marine fungal isolate, sp. strain GAD7, which produces an acidic and sulfated extracellular polysaccharide (EPS) with notable anticoagulant and antioxidant properties. Six fungal strains from the...
8.
Imaura R, Kawata Y, Matsuo K
Langmuir
. 2024 Sep;
40(39):20537-20549.
PMID: 39285698
α-Synuclein (αS) causes Parkinson's disease due to the structural alteration into amyloid fibrils that form after the interaction with synaptic membranes in neurons. To understand the alternation mechanism, the effect...
9.
Higashi M, Nakano T, Sato K, Eguchi Y, Moriwaki N, Kamada M, et al.
J Clin Med Res
. 2024 Aug;
16(7-8):325-334.
PMID: 39206105
Background: Vancomycin regimens are designed to achieve an area under the concentration-time curve/minimum inhibitory concentration (AUC/MIC) ratio ranging between 400 and 600 µg·h/mL in the steady state. However, in cases...
10.
Fujii K, Izumi Y, Maita N, Matsuo K, Kato M
Chirality
. 2024 Aug;
36(8):e23707.
PMID: 39129227
To reveal the structural mechanism by which the low-complexity domain of the fused in sarcoma protein (FUS-LC) mediates liquid-liquid phase separation (LLPS), we conducted a vacuum-ultraviolet circular dichroism (VUV-CD) spectroscopic...